| ME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma (NCT04517435) | Deepa Jagadeesh | 2021-04-28 |
| Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome (NCT03708900) | RECORDATI GROUP | 2021-04-28 |
| Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers. (NCT04871815) | Cellular Sciences, inc. | 2021-04-27 |
| Sargramostim Use in COVID-19 to Recover Patient Health (NCT04707664) | Partner Therapeutics, Inc. | 2021-04-27 |
| Efficacy and Safety of BN101 in Subjects With Chronic Graft Versus Host Disease (cGVHD) (NCT04930562) | BioNova Pharmaceuticals (Shanghai) LTD. | 2021-04-27 |
| Effectiveness of Zinc Supplementation With Topical Retinoids in Acne Vulgaris Patients (NCT04899843) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2021-04-27 |
| A Study to Test the Effect of Different Doses of Avenciguat (BI 685509) on Kidney Function in People With Chronic Kidney Disease (NCT04736628) | Boehringer Ingelheim | 2021-04-27 |
| Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma (NCT04850846) | Dana-Farber Cancer Institute | 2021-04-27 |
| Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma (NCT04671667) | National Cancer Institute (NCI) | 2021-04-27 |
| Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT (NCT05124353) | Pomeranian Medical University Szczecin | 2021-04-27 |
| Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD) (NCT04784416) | NYU Langone Health | 2021-04-27 |
| A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease (NCT04750577) | Boehringer Ingelheim | 2021-04-27 |
| Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial (NCT04865107) | Ottawa Hospital Research Institute | 2021-04-27 |
| Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes (NCT04764968) | Steno Diabetes Center Copenhagen | 2021-04-27 |
| Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma (NCT04776525) | Oslo University Hospital | 2021-04-27 |
| Evaluation of ADG20 for the Prevention of COVID-19 (NCT04859517) | Invivyd, Inc. | 2021-04-27 |
| A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3) (NCT04771273) | Boehringer Ingelheim | 2021-04-27 |
| Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Moderate COVID-19 (NCT05184127) | National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia | 2021-04-27 |
| Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia (NCT04822883) | Recognify Life Sciences | 2021-04-26 |
| Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection (NCT05269329) | Valenta Pharm JSC | 2021-04-26 |
| Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST) (NCT04590118) | Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd. | 2021-04-26 |
| Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP (NCT04720261) | University Hospital, Rouen | 2021-04-26 |
| Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep (NCT04625101) | Neurocrine Biosciences | 2021-04-26 |
| JAB-3068 Activity in Adult Patients With Advanced Solid Tumors (NCT04721223) | Jacobio Pharmaceuticals Co., Ltd. | 2021-04-26 |
| A Study of ABTL0812 in Pancreatic Cancer (NCT03417921) | Ability Pharmaceuticals SL | 2021-04-26 |
| Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints (NCT04871854) | Beni-Suef University | 2021-04-26 |
| Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations (NCT04550494) | National Cancer Institute (NCI) | 2021-04-26 |
| Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients (NCT04375956) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-04-26 |
| Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection (NCT03601806) | AIDS Malignancy Consortium | 2021-04-26 |
| Fruquitinib Combined With Camrelizumab in Non MSI-H/dMMR Refractory Colorectal Cancer (NCT04866862) | The First Affiliated Hospital with Nanjing Medical University | 2021-04-26 |
| A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19 (NCT04869592) | National Vaccine and Serum Institute, China | 2021-04-25 |
| Neoadjuvant Targeting of Myeloid Cell Populations in Combination With Nivolumab in Head & Neck Ca (NCT04848116) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-04-24 |
| COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol (NCT04662060) | Stanford University | 2021-04-23 |
| A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (NCT04832854) | Hoffmann-La Roche | 2021-04-23 |
| COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol (NCT04662073) | Stanford University | 2021-04-23 |
| Nitrites, Skeletal Muscle Mitochondrial Bioenergetics, and Physical Activity in Old Age (NCT04405180) | Gladwin, Mark, MD | 2021-04-23 |
| Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor (NCT05278364) | Shouyao Holdings (Beijing) Co. LTD | 2021-04-23 |
| Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration (NCT05011474) | Inbo Han | 2021-04-23 |
| A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors (NCT04836663) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-04-23 |
| Supplements, Placebo, or Rosuvastatin Study (NCT04846231) | The Cleveland Clinic | 2021-04-23 |
| Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease (IMPROVE-Ischemia) (NCT04826172) | Imbria Pharmaceuticals, Inc. | 2021-04-23 |
| Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects of Both Genders With Eosinophilic Esophagitis (EoE) (NCT05214599) | Bazell Pharma AG | 2021-04-23 |
| A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer (NCT04818333) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-23 |
| A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (NCT04868162) | Shanghai Miracogen Inc. | 2021-04-23 |
| Comparative Study of Abiraterone Acetate Tablets (I) or ZYTIGA® in Patients With Metastatic Castration-resistant Prostate Cancer (NCT04862091) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-23 |
| COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol (NCT04662086) | Stanford University | 2021-04-23 |
| Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone. (NCT04681287) | Henan Cancer Hospital | 2021-04-23 |
| Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3) (NCT04880434) | Kite, A Gilead Company | 2021-04-23 |
| Efficacy and Safety of SHR-1020 Combined With Albumin-bound Paclitaxel in the Second-line Treatment of Pancreatic Cancer (NCT04814485) | Tianjin Medical University Cancer Institute and Hospital | 2021-04-22 |
| Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma (NCT04897477) | Chinese PLA General Hospital | 2021-04-22 |
| DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia (NCT04775953) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-04-22 |
| Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors (NCT05865925) | Luye Pharma Group Ltd. | 2021-04-22 |
| Liver Transplantation With Tregs at UCSF (NCT03654040) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-04-22 |
| T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer (NCT04611126) | Inge Marie Svane | 2021-04-22 |
| Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose (NCT05378191) | Instituto de Investigación Hospital Universitario La Paz | 2021-04-22 |
| Vaginal Microbiota Transplant (NCT04046900) | Douglas Kwon | 2021-04-22 |
| A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection (NCT04966234) | Bambino Gesù Hospital and Research Institute | 2021-04-22 |
| Efficacy and Safety of Low-dose Decitabine in Refractory Aplastic Anemia (NCT04854889) | Institute of Hematology & Blood Diseases Hospital, China | 2021-04-22 |
| Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2) (NCT04681651) | Capital Medical University | 2021-04-22 |
| LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve (NCT04752722) | enGene, Inc. | 2021-04-22 |
| A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors (NCT04775485) | Day One Biopharmaceuticals, Inc. | 2021-04-22 |
| Tumor Response Time of Palbociclib in Combination With AI in Real-world Chinese Patients (NCT04858997) | Zhejiang Cancer Hospital | 2021-04-22 |
| A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension (NCT04959305) | Hanmi Pharmaceutical Company Limited | 2021-04-22 |
| Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT (NCT04271436) | Washington University School of Medicine | 2021-04-22 |
| Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation (NCT04840992) | CanSino Biologics Inc. | 2021-04-21 |
| Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides (NCT04676087) | Emory University | 2021-04-21 |
| Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP) (NCT04630158) | Novartis Pharmaceuticals | 2021-04-21 |
| MTX and Steroid for III-IV aGVHD Treatment (NCT04958538) | Peking University People's Hospital | 2021-04-21 |
| A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19 (NCT04822701) | Boehringer Ingelheim | 2021-04-21 |
| A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg Ulcers (NCT04817228) | MediWound Ltd | 2021-04-21 |
| GPR119 Agonist for Hypoglycemia in Type 1 Diabetes (NCT04432090) | AdventHealth Translational Research Institute | 2021-04-21 |
| Glumetinib Combined With Toripalimab in the Treatment of Relapsed or Metastatic Non-small Cell Lung Cancer. (NCT04797702) | Shanghai Junshi Bioscience Co., Ltd. | 2021-04-21 |
| Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast Cancer (NCT04720729) | Institut Curie | 2021-04-21 |
| Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide (NCT04997317) | University Hospital, Basel, Switzerland | 2021-04-21 |
| Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19 (NCT04674566) | Corat Therapeutics Gmbh | 2021-04-21 |
| A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer (NCT04683679) | Memorial Sloan Kettering Cancer Center | 2021-04-21 |
| Prevention of Acute Kidney Injury in Patients With NSTEMI (NCT04912141) | Pharming Technologies B.V. | 2021-04-21 |
| IMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpEF (Pt 2) (NCT04826159) | Imbria Pharmaceuticals, Inc. | 2021-04-21 |
| Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer (NCT04699838) | Muhammad Furqan | 2021-04-20 |
| Daratumumab to Treat Active Lupus Nephritis (NCT04868838) | Mayo Clinic | 2021-04-20 |
| Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia (NCT04951362) | South Valley University | 2021-04-20 |
| Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer (NCT04442581) | University of Washington | 2021-04-20 |
| Pyrotinib Plus Neoadjuvant Chemotherapy in HR+/HER2-, HER4-High Breast Cancer (NCT04872985) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-04-20 |
| Annexin A5 in Patients With Severe COVID-19 Disease (NCT04748757) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2021-04-20 |
| Safety, Efficacy, and Tolerability of NBI-827104 for the Treatment of Essential Tremor (NCT04880616) | Neurocrine Biosciences | 2021-04-20 |
| Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002, KEYVIBE-002) (NCT04725188) | Merck Sharp & Dohme LLC | 2021-04-20 |
| A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM) (NCT04776018) | Takeda | 2021-04-20 |
| ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults (NCT04856865) | Alladapt Immunotherapeutics, Inc. | 2021-04-20 |
| Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT (NCT04850157) | Shanghai Zhongshan Hospital | 2021-04-20 |
| A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis. (NCT04836858) | Novartis Pharmaceuticals | 2021-04-20 |
| Investigating the Minimum Number of Needling Required to Optimize Trigger Point Injections Outcome (NCT04732507) | University of Arizona | 2021-04-20 |
| Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 Mutation (NCT04869475) | Ruijin Hospital | 2021-04-20 |
| PD-1 Antibody and Lenvatinib Plus TACE-HAIC for Potential Resectable HCC: a Single-arm, Phase 2 Clinical Trial (NCT04814043) | Sun Yat-sen University | 2021-04-20 |
| Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19 (NCT06676709) | Universidad Autonoma de Nuevo Leon | 2021-04-20 |
| A Study of MRG002 in the Treatment of HER2-positive Unresectable Locally Advanced or Metastatic Urothelium Cancer (NCT04839510) | Shanghai Miracogen Inc. | 2021-04-20 |
| Acupuncture for the Treatment of Medication-Dependent Hypotension in Heart Failure (NCT04952935) | Scripps Health | 2021-04-20 |
| Transarterial Infusion of PD-1 Antibody Plus TACE-HAIC for Unresectable HCC: a Single-arm, Phase 2 Clinical Trial (NCT04814030) | Sun Yat-sen University | 2021-04-20 |
| Effect of RO7049665 on the Time to Relapse Following Steroid Tapering in Participants With Autoimmune Hepatitis (AIH) (NCT04790916) | Hoffmann-La Roche | 2021-04-19 |
| Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer (NCT04833205) | Hui Bu | 2021-04-19 |
| Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy (NCT04758533) | Hospital Infantil Universitario Niño Jesús, Madrid, Spain | 2021-04-19 |